Biomarkers of cancer risk in patients with underlying liver disease. Inflammation associated cancer initiation, promotion, and metastatic potential. Surgical and non-surgical therapies for primary and secondary tumors of the liver.
Potential role of the supporting cells (i.e. stromal cells) in the way cancer grows and spreads within other areas of the liver and outside the liver.
